University of Maryland School of Medicine, Division of Pulmonary and Critical Care Medicine, 110 South Paca Street, Baltimore, MD 21201, USA.
Respir Med. 2011 Dec;105(12):1961-8. doi: 10.1016/j.rmed.2011.10.003. Epub 2011 Oct 21.
Severe chronic obstructive pulmonary disease is associated with high HDL cholesterol (HDL-C). We sought to examine the effect of lung transplantation on lipid profiles in patients with COPD.
We analyzed 101 lung transplant recipients in a retrospective cohort of patients from two centers in whom lipid values were available both before as well as after transplantation. Sixty-one subjects were transplanted for severe COPD (93% GOLD stage 4).
Eighty-nine percent of subjects with COPD exhibited a decline in HDL-C. Median decline for the COPD cohort was 25 mg/dL (IQR 12-38 mg/dL, p < 0.0001). Non-COPD subjects exhibited no significant changes in HDL-C. Other lipid changes in the COPD cohort included a rise in triglycerides of 70 mg/dL (IQR 35 to 140, p < 0.0001). Decreases in HDL-C levels were independent from the rise in triglyceride levels. Neither LDL-C nor non-HDL-C demonstrated significant changes. Subjects with greater increases in prednisone exposure post-transplant exhibited lesser declines in HDL-C. Compared with tacrolimus, cyclosporine had no effect on observed changes in HDL-C or triglycerides, but was associated with a greater median rise in LDL-C.
In patients with COPD, lung transplantation results in reductions in the serum levels of HDL-C. These changes are not observed in patients undergoing lung transplantation for diagnoses other than COPD.
严重的慢性阻塞性肺疾病与高密度脂蛋白胆固醇(HDL-C)升高有关。我们试图研究肺移植对 COPD 患者脂质谱的影响。
我们分析了来自两个中心的 101 例肺移植受者的回顾性队列研究,这些受者在移植前后均有血脂值。61 例患者因严重 COPD(93%GOLD 分期 4 期)接受肺移植。
89%的 COPD 患者 HDL-C 下降。COPD 队列的中位数下降了 25mg/dL(IQR 12-38mg/dL,p<0.0001)。非 COPD 患者的 HDL-C 无明显变化。COPD 队列中的其他脂质变化包括甘油三酯升高 70mg/dL(IQR 35-140,p<0.0001)。HDL-C 水平的降低与甘油三酯水平的升高无关。LDL-C 和非 HDL-C 均无明显变化。移植后泼尼松暴露增加的患者,HDL-C 下降幅度较小。与他克莫司相比,环孢素对观察到的 HDL-C 或甘油三酯变化没有影响,但与 LDL-C 中位数升高有关。
在 COPD 患者中,肺移植导致血清 HDL-C 水平降低。这些变化在因 COPD 以外的诊断接受肺移植的患者中观察不到。